Results

Total Results: 1,678 records

Showing results for "women".
Users also searched for: patient experience

181. Archived: Final Research Plan: Iron Deficiency Anemia in Pregnant Women: Screening and Supplementation | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan31/iron-deficiency-anemia-in-pregnant-women-screening-and-supplementation-september-2015
     July 15, 2013 - On the left side of the framework, the population includes all pregnant women. … What are the harms of routine iron supplementation in pregnant women? … What are the harms of screening for iron deficiency anemia in pregnant women? … What are the harms of iron treatment in pregnant women? … Routine Iron Supplementation in Pregnant Women Populations Pregnant adolescents and women and

182. Archived: Ovarian Cancer: Screening, May 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening-2004
     May 04, 2004 - 2 percent (i.e., 98 percent of women with positive test results will not have ovarian cancer). … example, the lifetime probability of ovarian cancer increases from about 1.6 percent in a 35-year-old woman … Should women with familial ovarian cancer undergo prophylactic oophorectomy? … Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. … A combined approach for the early detection of ovarian cancer in asymptomatic women.

183. Archived: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer--brca-testing-ovarian-cancer-screeni
     September 15, 2005 - B Women, Not at Increased Risk The U.S. … In a woman who has a clinically important BRCA mutation, the probability of developing breast or ovarian … basis of the patient's respective risk categories. 34 The interventions that can be offered to a woman … Risk of breast and ovarian cancer in women with strong family histories. … BRCA1 sequence analysis in women at high risk for susceptibility mutations.

184. Archived: Final Evidence Review: Ovarian Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review78/ovarian-cancer-screening-2012
     April 15, 2012 - Of these 1,706 women, 541 (31.7 percent) had surgery without a diagnosis of cancer. … Thirty nine of 79 practices in the study recruited 317 women between 2002 and 2005; 315 women were eligible … Only three women (representing 8 percent of women with an abnormal test result, or 1 percent of the 290 … women referred for screening) had surgery to evaluate an ovarian abnormality. … out of 15 women with incidental findings), who were only investigated further if the women were symptomatic

185. Archived: Hepatitis B in Pregnant Women: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-in-pregnant-women-screening
     June 15, 2009 - archived Final Recommendation Statement Hepatitis B in Pregnant Women: Screening June … Population All Pregnant Women Recommendation Screen at the first prenatal visit. … Refer women who test positive for counseling and medical management.  … -born pregnant women. … Screening for hepatitis B virus infection in pregnant women: evidence for the U.S.

186. Summary of USPSTF Final Recommendation: Screening for Breast Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Qs4k3tBM8wdzudSpKro7-U
     April 01, 2024 - B Grade Women aged 40 to 74 years: The USPSTF recommends biennial screening mammography. … I Statement Women 75 years or older: The current evidence is insufficient to assess the balance … of benefits and harms of screening mammography in women 75 years or older. … • Screen women aged 40 to 74 with a mammogram every 2 years. … In 2023, an estimated 43,170 women died of breast cancer.

187. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/GcjfCZtGpACQMv2KScLbEu
     June 11, 2019 - 2 What are the harms of screening for HIV infection in pregnant women? … What are the harms of screening for HIV infection in pregnant women? … There was no significant difference in echocardio- graphic parameters in boys, but in girls combination … HIV/AIDS HIV among pregnant women, infants, and children. … HIV/AIDS HIV among women. CDC website. https://www.cdc.gov/hiv/group/gender/women/. 2016.

188. USPSTF Recommends Against Screening for Ovarian Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/ovarian-cancer-final-rec-bulletin.pdf
     February 13, 2018 - Preventive Services Task Force Recommends Against Screening for Ovarian Cancer For women without signs … Learn more here Ovarian cancer is hard to detect, and many women do not show signs or symptoms in the … Unfortunately, current screening tests do not accurately identify if a woman has, or does not have, … Therefore, screening may lead to a woman having unnecessary surgery to remove one or both ovaries when … that screening can lead to unnecessary surgery in women without cancer”.

189. U.S. Preventive Services Task Force Issues Final Recommendation Statement on Screening for Gynecologic Conditions With Pelvic Examination (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/pelvic-exam-final-news-bulletin.pdf
     March 07, 2017 - research is needed for the Task Force to recommend for or against performing pelvic exams in adult women … statement and evidence summary on screening for gynecologic conditions with pelvic examination in women … effectiveness of the pelvic exam, a type of physical exam, which is different than the annual well-woman … The Task Force does not have a recommendation on annual well-woman visits. … The I statement applies to women age 18 and older who do not have any signs or symptoms of gynecologic

190. Evidence Summary: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/asymptomatic-bacteriuria-in-adults-screening
     September 24, 2019 - One study among nonpregnant women reported that there were no adverse drug reactions among the 49 women … Thus,women at risk of developing pyelonephritis in pregnancy, particularly women with limited access … The clinical significance of asymptomatic bacteriuria in the nonpregnant woman. … (84%-100% women in each study); 3 studies limited to older adults (2 of 3 limited to older women); 1 … study limited to women with diabetes KQ4: Treatment Harms Pregnant women 7 RCTs (1286

191. Archived: Evidence Summary (Pregnant and Postpartum Women): Screening for Depression in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-primary-care-screening-for-and-treatment-of/depression-in-adults-screening
     January 26, 2016 - Evidence for pregnant women was sparser but was consistent with the evidence for postpartum women regarding … Five trials focused on postpartum women, 22 , 26-28 , 30 and the sixth focused on pregnant women. … 29 All trials studied women identified in health care settings and included all study-eligible women … among pregnant women suggested comparable effect with postpartum women Important limitations to the … Pragmatically, CBT is not an option for every depressed woman because some will not want such therapy

192. Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
     April 01, 2013 - ; subanalysis on screening population; 52 case participants among 1933-woman cohort Women whose risk … without breast cancer; aged 35–84 y from 1996–2001 11 638 case participants from 2 392 998-woman cohort … 2009: median follow-up, 14.6 y (86.7% �5 y) 331 case participants with atypical hyperplasia in 9376-woman … 2569 case participants with 2588 control participants Validation: 194 case participants in 10 031-woman … aged 45–71 y in 1992; study duration, 1992–1997 1354 case participants in 82 109-woman cohort Validation

193. Archived: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-and-ovarian-cancer-brca-testing-screening-2005
     September 15, 2005 - B Women, Not at Increased Risk The U.S. … In a woman who has a clinically important BRCA mutation, the probability of developing breast or ovarian … basis of the patient's respective risk categories. 34 The interventions that can be offered to a woman … Risk of breast and ovarian cancer in women with strong family histories. … BRCA1 sequence analysis in women at high risk for susceptibility mutations.

194. Evidence Summary: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing
     August 20, 2019 - Effects of counseling Ashkenazi Jewish women about breast cancer risk. … Development of a risk assessment tool for women with a family history of breast cancer. … Genetic counseling for women with an intermediate family history of breast cancer. … Psychological impact of genetic testing in women from high-risk breast cancer families. … Exemestane for breast-cancer prevention in postmenopausal women.

195. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/RGu5KsFRY2YEAsDC9EQox9
     December 31, 2013 - Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Clinical Summary … Recommendation RISK ASSESSMENT, GENETIC COUNSELING, AND GENETIC TESTING FOR BRCA-RELATED CANCER IN WOMEN … PREVENTIVE SERVICES TASK FORCE RECOMMENDATION Population Asymptomatic women who have not been diagnosed … with BRCA-related cancer Recommendation Screen women whose family history may be associated … Grade: B Do not routinely recommend genetic counseling or BRCA testing to women whose family history

196. U.S. Preventive Services Task Force Issues Three Recommendations on Prevention and Detection of Sexually Transmitted Infections (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/sti_gonchlamfinalrsbulletin.pdf
     September 23, 2014 - Behavioral Counseling to Prevent Sexually Transmitted Infections and Screening Some Sexually Active Women … ages 24 years and younger and older women who are at increased risk for infection. … Additionally, the Task Force found evidence that screening women ages 24 years and younger (who have … “If a woman has an STI that is left untreated, she may be at higher risk for serious and long-term complications … and also older women at increased risk.”

197. Screening for Ovarian Cancer: Evidence Update for the USPTF Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/fNXdu3HGvWE-ovsuhNeANW
     April 01, 2012 - Of these 1,706 women, 541 (31.7 percent) had surgery without a diagnosis of cancer. … between 2002 and 2005; 315 women were eligible and 290 attended screening. … Only three women (representing 8 percent of women with an abnormal test result, or 1 percent of the … 290 women referred for screening) had surgery to evaluate an ovarian abnormality. … (out of 15 women with incidental findings), who were only investigated further if the women were symptomatic

198. Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication
     December 12, 2017 - using hormone therapy and women receiving placebo. … Nevertheless, secondary analyses of the WHI limited to adherent women (ie, censoring women within 6 months … Fourth, the majority of women (around 80%) were white. … Estrogen plus progestin and colorectal cancer in postmenopausal women. … a Not applicable to women after hysterectomy.

199. Archived: Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication-december-2017
     December 12, 2017 - using hormone therapy and women receiving placebo. … Nevertheless, secondary analyses of the WHI limited to adherent women (ie, censoring women within 6 months … Fourth, the majority of women (around 80%) were white. … Estrogen plus progestin and colorectal cancer in postmenopausal women. … a Not applicable to women after hysterectomy.

200. Medications for Risk Reduction of Primary Breast Cancer in Women: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/eUBUXRUJHua5Q44j_THFn2
     October 30, 2013 - Medications for Risk Reduction of Primary Breast Cancer in Women: Clinical Summary of USPSTF Recommendation … MEDICATIONS FOR RISK REDUCTION OF PRIMARY BREAST CANCER IN WOMEN CLINICAL SUMMARY OF U.S. … PREVENTIVE SERVICES TASK FORCE RECOMMENDATION Population Asymptomatic women aged ≥35 years without … a prior diagnosis of breast cancer who are at increased risk for the disease Asymptomatic women aged … for this use in postmenopausal women.